Ewa Paszkiewicz-Kozik

4PUBLICATIONS
48CO-AUTHORS
Respiratory diseasesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 10, 2026
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

|Apr 01, 2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.

Ewa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner

|Oct 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.

Pier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro

|Feb 25, 2021
Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.

Ewa Paszkiewicz-Kozik, Agnieszka Paziewska, Maria Kulecka

Pageof 1

Frequent Collaborators

2 joint publications

Joanna Romejko-Jarosińska

1 joint publications

Agnieszka Paziewska

1 joint publications

Maria Kulecka

1 joint publications

Michalina Dąbrowska